Aspirin trialled as potential treatment for aggressive breast cancer

The trial is the first clinical study to test if aspirin can make tumours more sensitive to immunotherapy in patients who have triple-negative breast cancer. Photograph: Jonathan Brady/PA

The trial is the first clinical study to test if aspirin can make tumours more sensitive to immunotherapy in patients who have triple-negative breast cancer. Photograph: Jonathan Brady/PA

source https://www.theguardian.com/science/2021/aug/18/aspirin-trialled-as-potential-treatment-for-aggressive-breast-cancer